Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study [PDF]
Deborah Obehi Onwusah,1 Elizabeth Bolanle Ojewole,1 Tawanda Manyangadze,2,3 Moses John Chimbari2,4 1Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South ...
Onwusah DO +3 more
doaj +2 more sources
Adherence to oral anticancer medications in metastatic versus nonmetastatic breast cancer patients: Insights from a low-middle-income country [PDF]
Background: Optimal treatment outcomes in breast cancer rely heavily on patient adherence to oral anticancer medications (OAMs). Aim: This study aimed to assess adherence to OAMs and identify factors associated with nonadherence in metastatic and ...
Abdel-Hameed I.M. Ebid +5 more
doaj +2 more sources
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries [PDF]
Purpose The high cost of oncology drugs threatens the affordability of cancer care. Previous research identified drivers of price growth of targeted oral anticancer medications (TOAMs) in private insurance plans and projected the impact of closing the coverage gap in Medicare Part D in 2020.
Ya-Chen Tina, Shih +3 more
openaire +3 more sources
User acceptance of an app-based adherence intervention: Perspectives from patients taking oral anticancer medications [PDF]
Background Widespread adoption by patients is imperative for the success of app-based interventions for enhancing adherence to oral anticancer medications. Patients' attitudes and beliefs should be evaluated to understand determinants of their acceptance and adoption of such interventions.
Eskinder Eshetu Ali +4 more
openaire +3 more sources
Discrepancies in Recommendations on Pharmacokinetic Drug Interactions for Anticancer Medications and Direct Oral Anticoagulants (DOAC): A Comparative Analysis of Different Clinical Decision Support Systems and Sources [PDF]
Background/objectives: In some cases of concomitant use of direct oral anticoagulants (DOAC) and certain anticancer medications, pharmacokinetic interactions are expected; however, clinical data is scarce.
Karolina Nowinski, Roza Chaireti
doaj +2 more sources
A Co-Design Study Developing an Early Prototype Intervention to Support Oral Anticancer Medication Use in Breast Cancer [PDF]
Yejin Seo,1 Karen Suchanek Hudmon,1 Kellie Jones Weddle,1 Yuehwern Yih,2 Kathy D Miller,3 Ephrem Abebe1,4 1College of Pharmacy, Purdue University, West Lafayette, IN, USA; 2Edwardson School of Industrial Engineering, Purdue University, West Lafayette, IN,
Seo Y +5 more
doaj +2 more sources
A Systematic Review of Methods to Measure Adherence to Oral Anticancer Medications in African Women With Breast Cancer at Initiation, Implementation, and Discontinuation of Therapy [PDF]
Deborah Obehi Onwusah +3 more
doaj +2 more sources
Nanomedicine for increasing the oral bioavailability of cancer treatments
Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications ...
Alessandro Parodi +7 more
doaj +1 more source
Assessment of Oral Anticancer Medication Adherence: A Survey from a Tertiary Cancer Center [PDF]
Abstract Background Adherence to oral anticancer medication is important in cancer chemotherapy, with the advent of many oral anticancer regimens to ensure adequate cytologic response. Literature on adherence to oral anticancer therapy in India is very less. Materials and Methods This is a cross sectional analytical study consisting
Balaji Ramachandiran +8 more
openaire +3 more sources
Importance of medication reconciliation in cancer patients
Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can lead to dire outcomes. This commentary aims to
Ali Elbeddini +3 more
doaj +1 more source

